Urothelial Bladder Cancer — Microlearning Activity 2 with Dr Terence Friedlander: ESMO Congress 2025 Review

Name: Urothelial Bladder Cancer — Microlearning Activity 2 with Dr Terence Friedlander: ESMO Congress 2025 Review
Uploaded: 2026-02-23T20:38:38+0000
Duration: 1409 s
Description: Featuring an interview with Dr Terence Friedlander, including the following topics: Perioperative durvalumab with neoadjuvant chemotherapy: Health-related quality-of-life outcomes in the NIAGARA trial (0:00) Targeting HER2 in locally advanced or metastatic urothelial carcinoma (5:17) TROP2-targeted

Posted on 02/23/2026

23:29 |

Featuring an interview with Dr Terence Friedlander, including the following topics:

Perioperative durvalumab with neoadjuvant chemotherapy: Health-related quality-of-life outcomes in the NIAGARA trial (0:00)
Targeting HER2 in locally advanced or metastatic urothelial carcinoma (5:17)
TROP2-targeted antibody-drug conjugates for locally advanced or metastatic urothelial carcinoma (18:19)

CME information and select publications